| Sub Cat | Immunogen | Isotype | Application | |
|---|---|---|---|---|
| V3S-1124-YC963 | Host cells overexpressing TES7 | IgG | FC; IHC; ELISA | |
| V3S-1022-YC2513 | MCF7 cells | IgG2a | ELISA; FC; IP | |
| V3S-0522-YC7279 | Human CD276 molecule | IgG | WB; ELISA; FuncS | |
| V3S-1022-YC2508 | Human neuroblastoma | IgG1 | WB; FC; IP |
| Description | The anti-TES7 antibody competitively inhibits the preferential binding of an anti-TES7 antibody to TES7. TES7 shares characteristics with the 4Ig form of B7-H3. The mouse anti-TES7 antibody preferentially binds to the four-Ig-loop B7-H3. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human |
| Immunogen | Host cells that over-express TES7 as an immunogen |
| Isotype | Mouse IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein G affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | FC; IHC; ELISA |
| Application Notes | FC: 1 μg/mL IHC: 1-5 μg/mL ELISA: 2-10 μg/mL |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
